Melatonin as a treatment for Delayed Sleep Phase Disorder

Summary

More about Professor Ron Grunstein Stay in touch

The project will characterise the behavioural and physiological phenotype of DSPD and examine the efficacy of melatonin as a treatment for DSPD.

Supervisor

Professor Ron Grunstein.

Research location

Camperdown - Woolcock Institute of Medical Research

Program type

PHD

Synopsis

Delayed Sleep Phase Disorder (DSPD) is a circadian rhythm disorder defined as a sleep schedule occurring substantially later than the conventional or desired time. Individuals which suffer from DSPD not only habitually rise later but also fall asleep later than they choose. 10-16% of individuals that suffer from DSPD are misclassified with insomnia and therefore, may be treated inappropriately. This study hopes to conduct a definitive study of melatonin for DSPD, with accurate diagnosis methods, optimal treatment timing and a pragmatic treatment approach. Through physiological phenotyping of DSPD we hope to provide an evidence-base to inform pharmacogenetic approaches to treating DSPD.

Want to find out more?

Interested in this opportunity? Want to know what to do next? Find out all you need to know about the application process including how to approach a potential supervisor via email and how to develop a research proposal.
Browse for other opportunities within the Camperdown - Woolcock Institute of Medical Research.
Contact us to find out what's involved in applying for a PhD. Domestic students and international students.

Opportunity ID

The opportunity ID for this research opportunity is 690